ATE462779T1 - Nukleinsäurefreie ghost zusammensetzungen - Google Patents

Nukleinsäurefreie ghost zusammensetzungen

Info

Publication number
ATE462779T1
ATE462779T1 AT02762349T AT02762349T ATE462779T1 AT E462779 T1 ATE462779 T1 AT E462779T1 AT 02762349 T AT02762349 T AT 02762349T AT 02762349 T AT02762349 T AT 02762349T AT E462779 T1 ATE462779 T1 AT E462779T1
Authority
AT
Austria
Prior art keywords
compositions
nucleic acid
free ghost
ghost
free
Prior art date
Application number
AT02762349T
Other languages
English (en)
Inventor
Werner Lubitz
Wolfgang Haidinger
Original Assignee
Lubitz Werner Prof Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubitz Werner Prof Dr filed Critical Lubitz Werner Prof Dr
Application granted granted Critical
Publication of ATE462779T1 publication Critical patent/ATE462779T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02762349T 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen ATE462779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30459501P 2001-07-11 2001-07-11
PCT/EP2002/007758 WO2003006630A2 (en) 2001-07-11 2002-07-11 Nucleic acid free ghost preparations

Publications (1)

Publication Number Publication Date
ATE462779T1 true ATE462779T1 (de) 2010-04-15

Family

ID=23177160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762349T ATE462779T1 (de) 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen

Country Status (8)

Country Link
US (1) US7399476B2 (de)
EP (1) EP1404808B1 (de)
AT (1) ATE462779T1 (de)
AU (1) AU2002328340B2 (de)
CA (1) CA2453518C (de)
DE (1) DE60235809D1 (de)
NZ (1) NZ530780A (de)
WO (1) WO2003006630A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
AU2009204952B2 (en) * 2008-01-18 2013-02-07 Werner Lubitz Bacterial ghost (BG) production process using betapropiolactone (BLP) for final inactivation
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
ES2525205T3 (es) 2011-11-09 2014-12-18 Werner Lubitz Vacuna para su uso en inmunoterapia tumoral
EP3195878A1 (de) 2016-01-22 2017-07-26 Werner Lubitz Bakterielle ghosts zur behandlung von krebs
JP7376208B2 (ja) 2017-10-25 2023-11-08 アレーロ セラピューティクス ビーヴイ 抗原特異的製剤の投与による免疫疾患の治療
CN112410360A (zh) * 2021-01-18 2021-02-26 西南大学 一种鸡病原细菌菌影及其制备方法和应用
EP4678183A1 (de) 2024-07-12 2026-01-14 Allero Therapeutics B.V. Behandlung von immunkrankheiten durch verabreichung von mrna-formulierungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
BR9407813A (pt) * 1993-10-13 1997-05-06 Gx Biosystems As Nucleases de staphylococcus recombinantes e seu uso na limitação da sobrevivencia de microorganismos elaborados por engenharia genética

Also Published As

Publication number Publication date
CA2453518A1 (en) 2003-01-23
WO2003006630A2 (en) 2003-01-23
DE60235809D1 (de) 2010-05-12
EP1404808A2 (de) 2004-04-07
NZ530780A (en) 2005-06-24
US20040213810A1 (en) 2004-10-28
CA2453518C (en) 2010-02-02
EP1404808B1 (de) 2010-03-31
AU2002328340B2 (en) 2007-06-28
US7399476B2 (en) 2008-07-15
WO2003006630A3 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
IL233223A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
ITRM980103A0 (it) Uso di batteri dotati di arginina deiminasi per introdurre apostosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
WO2008057529A3 (en) Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
BR0010721A (pt) Composições de neisserias combinadas
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
EP2322200A3 (de) Gestaltungen und Methoden für die Behandlung von immune verwandte Krankheiten
BR0207394A (pt) Proteìna de fusão para a secreção de uma proteìna de interesse no sobrenadante da cultura bacteriana
WO2008052173A3 (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
WO2002024883A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
EP1572084A4 (de) Säugetiergene mit beteiligung an virusinfektion und tumorsuppression
ATE314084T1 (de) Kahalalid f formulierung
DE60235809D1 (de) Nukleinsäurefreie ghost zusammensetzungen
IT1270618B (it) Proteine ad attivita' antitumorale
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
TW200716226A (en) Compositions comprising actinidia and methods of use thereof
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
DK0811068T3 (da) Humane DNase I varianter
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404808

Country of ref document: EP